These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35387632)
1. Hinokiflavone induces apoptosis, cell cycle arrest and autophagy in chronic myeloid leukemia cells through MAPK/NF-κB signaling pathway. Qin X; Chen X; Guo L; Liu J; Yang Y; Zeng Y; Li C; Liu W; Ma W BMC Complement Med Ther; 2022 Apr; 22(1):100. PubMed ID: 35387632 [TBL] [Abstract][Full Text] [Related]
2. Hinokiflavone induces apoptosis via activating mitochondrial ROS/JNK/caspase pathway and inhibiting NF-κB activity in hepatocellular carcinoma. Mu W; Cheng X; Zhang X; Liu Y; Lv Q; Liu G; Zhang J; Li X J Cell Mol Med; 2020 Jul; 24(14):8151-8165. PubMed ID: 32519392 [TBL] [Abstract][Full Text] [Related]
3. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353 [TBL] [Abstract][Full Text] [Related]
4. Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells. He W; Ye X; Huang X; Lel W; You L; Wang L; Chen X; Qian W Int J Oncol; 2016 Apr; 48(4):1710-20. PubMed ID: 26892093 [TBL] [Abstract][Full Text] [Related]
5. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway. Wei YL; Liang Y; Xu L; Zhao XY Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306 [TBL] [Abstract][Full Text] [Related]
6. Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling. Hao G; Zhai J; Jiang H; Zhang Y; Wu M; Qiu Y; Fan C; Yu L; Bai S; Sun L; Yang Z Biomed Pharmacother; 2020 Feb; 122():109677. PubMed ID: 31810012 [TBL] [Abstract][Full Text] [Related]
7. Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl. Lu Z; Jin Y; Chen C; Li J; Cao Q; Pan J Mol Cancer; 2010 May; 9():112. PubMed ID: 20482842 [TBL] [Abstract][Full Text] [Related]
8. Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells. Lernoux M; Schnekenburger M; Losson H; Vermeulen K; Hahn H; Gérard D; Lee JY; Mazumder A; Ahamed M; Christov C; Kim DW; Dicato M; Bormans G; Han BW; Diederich M Clin Epigenetics; 2020 May; 12(1):69. PubMed ID: 32430012 [TBL] [Abstract][Full Text] [Related]
9. Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation. Chandramohan Reddy T; Bharat Reddy D; Aparna A; Arunasree KM; Gupta G; Achari C; Reddy GV; Lakshmipathi V; Subramanyam A; Reddanna P Toxicol In Vitro; 2012 Apr; 26(3):396-405. PubMed ID: 22245431 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines. Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223 [TBL] [Abstract][Full Text] [Related]
11. Simvastatin in combination with bergamottin potentiates TNF-induced apoptosis through modulation of NF-κB signalling pathway in human chronic myelogenous leukaemia. Kim SM; Lee EJ; Lee JH; Yang WM; Nam D; Lee JH; Lee SG; Um JY; Shim BS; Ahn KS Pharm Biol; 2016 Oct; 54(10):2050-60. PubMed ID: 26911804 [TBL] [Abstract][Full Text] [Related]
12. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells. Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463 [TBL] [Abstract][Full Text] [Related]
13. Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation. Lee J; Zhang G; Wu X; Xu F; Zhou J; Zhang X J Cancer Res Clin Oncol; 2012 Dec; 138(12):2095-102. PubMed ID: 22833150 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia. Chorzalska A; Ahsan N; Rao RSP; Roder K; Yu X; Morgan J; Tepper A; Hines S; Zhang P; Treaba DO; Zhao TC; Olszewski AJ; Reagan JL; Liang O; Gruppuso PA; Dubielecka PM Mol Oncol; 2018 May; 12(5):630-647. PubMed ID: 29485707 [TBL] [Abstract][Full Text] [Related]
15. Characterization of cancer stem cells in chronic myeloid leukaemia. Jørgensen HG; Holyoake TL Biochem Soc Trans; 2007 Nov; 35(Pt 5):1347-51. PubMed ID: 17956348 [TBL] [Abstract][Full Text] [Related]
16. CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment. Zhang H; Chang G; Wang J; Lin Y; Ma L; Pang T Leuk Res; 2013 Nov; 37(11):1583-91. PubMed ID: 24125838 [TBL] [Abstract][Full Text] [Related]
17. GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia. Han SH; Korm S; Han YG; Choi SY; Kim SH; Chung HJ; Park K; Kim JY; Myung K; Lee JY; Kim H; Kim DW Autophagy; 2019 Dec; 15(12):2076-2090. PubMed ID: 30929559 [TBL] [Abstract][Full Text] [Related]
18. [Chloroquine Enhances BIIB021-induced Apoptosis in Chronic Myeloid Leukemia Cells Bearing T315I Mutation]. He W; Zhao CF; Chen L; Hu HX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1005-1010. PubMed ID: 35981354 [TBL] [Abstract][Full Text] [Related]
19. The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia. Chen Y; Wang T; Du J; Li Y; Wang X; Zhou Y; Yu X; Fan W; Zhu Q; Tong X; Wang Y Cell Physiol Biochem; 2018; 47(3):981-993. PubMed ID: 29843123 [TBL] [Abstract][Full Text] [Related]
20. PI3K/mTOR dual-inhibition with VS-5584 enhances anti-leukemic efficacy of ponatinib in blasts and Ph-negative LSCs of chronic myeloid leukemia. Kayabasi C; Yelken BO; Asik A; Okcanoglu TB; Sogutlu F; Gasimli R; Susluer SY; Saydam G; Avci CB; Gunduz C Eur J Pharmacol; 2021 Nov; 910():174446. PubMed ID: 34461124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]